| Characteristic | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
Download
Sources
Release date
January 2019
Region
United States
Survey time period
2010 to 2017
Supplementary notes
* Includes prescription retail and hospital markets.
MEQ = morphine equivalents.
Citation formats









